DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / M•• C•••••• M••••••••• L•
M•• C•••••• M••••••••• L•
M28 Capital is a healthcare sector fund that hopes to generate investment returns from the ongoing biotechnology and human health revolution by allocating capital to the most impactful companies poised to create substantial shareholder value in the biotechnology and pharmaceutical industry.
venture manager, reported GAV $14.2M across 2 vehicles
Importance
5
low
Active deployment
0
low
Emerging
0
low
Completeness
63
high
Freshness
98
high
Research priority
1
low
Identity and regulatory footprint
- Headquarters
- Stamford, CTadviserinfo.sec.gov
- Office address
- 700 CANAL STREET, 1ST FLOOR, Stamford, CT, 06902adviserinfo.sec.gov
- Business phone
- (203) 516-3747adviserinfo.sec.gov
- Website
- m•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Apr 22, 2026
- Private funds reported
- 3 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $113Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Regulatory AUM
- $158Mthe adviser's RAUM, a regulatory measure, never a fund size
- Employees
- 4
- Owners on Schedule A
- M•• C•••••• M••••••••• G• L•• (General Partner), NA
- business email
- marc@m28capital.comm28capital.compublished by the subject
- business phone
- (203) 516-3730adviserinfo.sec.govpublished by the subject
- business phone
- (203) 516-3747adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| S•••••••• L• | Fund | 2022 adv first reported | Active deployment | $8.0M Mar 29, 2024 | 2 | unknown | unknown |
| V••••• A•••••• L• | Fund | 2020 adv first reported | Mature | $6.2M Mar 29, 2024 | 27 | $0 | Jun 10, 2020 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
2 current, 0 departed
M••• W•••••• E•••
Managing partnerManaging Member · since Oct 1, 2019
C••••••••• M•••••• T••••••••
Platform and operationsPresident & Chief Compliance Officer · since Oct 1, 2019
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
- Sep 14, 2026M•• C•••••• M••••••••• L•: INSTITUTIONAL_VC -> MICRO_VC (venture manager, reported GAV $14.2M across 2 vehicles)Classification changedClassificationInferenceno URL
- Mar 30, 2022S•••••••• L• first reported on Form ADV by M•• C•••••• M••••••••• L• (Venture Capital Fund), GAV $8,069,764Fund first reported on Form ADVFundsFactS•••••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 6, 2020V••••• A•••••• L• first reported on Form ADV by M•• C•••••• M••••••••• L• (Venture Capital Fund), GAV $5,125,000Fund first reported on Form ADVFundsFactV••••• A•••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 14, 2020M•• C•••••• M••••••••• L• first filed Form ADV (IA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 14, 2026Micro VC (probable, 80%, cls-1)venture manager, reported GAV $14.2M across 2 vehicles
- Sep 12, 2026Institutional venture firm (probable, 80%, cls-1)venture manager, reported GAV $141M across 3 vehicles
Evidence
43 observations from 3 sources